Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis

被引：0

作者：

Hauser, S. L. ^{[1
]}

Kappos, L. ^{[2
]}

Montalban, X. ^{[3
,4
]}

Hughes, R. ^{[5
]}

Koendgen, H. ^{[5
]}

McNamara, J. ^{[6
]}

Pradhan, A. ^{[7
]}

Wormser, D. ^{[5
]}

Wolinsky, J. S. ^{[8
]}

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94143 USA

[2] Univ Basel, Univ Hosp Basel, Basel, Switzerland

[3] Univ Toronto, Div Neurol, Toronto, ON, Canada

[4] Vall dHebron Univ Hosp, Barcelona, Spain

[5] F Hoffmann La Roche Ltd, Basel, Switzerland

[6] John McNamara Consulting Ltd, Cambridge, England

[7] Genentech Inc, San Francisco, CA 94080 USA

[8] UTHealth, McGovern Med Sch, Houston, TX USA

来源：

MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷

基金：

新加坡国家研究基金会;

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1229

引用

页码：697 / 698

页数：2

共 50 条

[1] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, S. L.
Kappos, L.
Montalban, X.
Craveiro, L.
Hughes, R.
McNamara, J.
Pradhan, A.
Wormser, D.
Koendgen, H.
Wolinsky, J. S.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 317 - 318
[2] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
Hauser, Stephen L.
Kappos, Ludwig
Montalban, Xavier
Craveiro, Licinio
Hughes, Richard
Prajapati, Kalpesh
Koendgen, Harold
Pradhan, Ashish
Wolinsky, Jerry S.
NEUROLOGY, 2020, 94 (15)
[3] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
Hauser, S. L.
Kappos, L.
Montalban, X.
Craveiro, L.
Hughes, R.
Prajapati, K.
Koendgen, H.
Pradhan, A.
Wolinsky, J. S.
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 331 - 331
[4] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
Hauser, Stephen L.
Kappos, Ludwig
Montalban, Xavier
Chognot, Cathy
Jessop, Nikki
Pradhan, Ashish
Prajapati, Kalpesh
Wolinsky, Jerry S.
NEUROLOGY, 2021, 96 (15)
[5] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, S. L.
Kappos, L.
Montalban, X.
Guittari, C. J.
Koendgen, H.
Li, C.
Marcillat, C.
Wormser, D.
Wolinsky, J. S.
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 324 - 325
[6] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
Hauser, Stephen
Kappos, Ludwig
Montalban, Xavier
Koendgen, Harold
Li, Carrie
Marcillat, Carole
Pradhan, Ashish
Wormser, David
Wolinsky, Jerry
NEUROLOGY, 2018, 90
[7] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, Stephen L.
Kappos, Ludwig
Montalban, Xavier
Guittari, Carol-Jean
Koendgen, Harold
Li, Carrie
Marcillat, Carole
Wormser, David
Wolinsky, Jerry
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP13 - NP13
[8] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, S. L.
Kappos, L.
Montalban, X.
Hughes, R.
McNamara, J.
Pradhan, A.
Wormser, D.
Koendgen, H.
Wolinsky, J. S.
EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 239 - 239
[9] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, Stephen
Kappos, Ludwig
Montalban, Xavier
Chognot, Cathy
Jessop, Nikki
Kadner, Karen
Pradhan, Ashish
Incera, Elodie
Wolinsky, Jerry
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 352 - 353
[10] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, S.
Kappos, L.
Montalban, X.
Chognot, C.
Craveiro, L.
Pradhan, A.
Prajapati, K.
Wolinsky, J.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 306 - 306

← 1 2 3 4 5 →